Fumiko Itoh

5PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 14, 2024
A MAP1B-cortactin-Tks5 axis regulates TNBC invasion and tumorigenesis.

Hiroki Inoue, Taku Kanda, Gakuto Hayashi

|Dec 19, 2023
CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment.

Kazuki Takahashi, Miho Kobayashi, Hisae Katsumata

|Jul 18, 2022
Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.

Kako Hanada, Kunpei Fukasawa, Hiroki Hinata

|Dec 01, 2021
Endothelial-specific depletion of TGF-β signaling affects lymphatic function.

Kunpei Fukasawa, Kako Hanada, Kei Ichikawa

|Jun 11, 2020
Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia.

Chiharu Ojima, Yuri Noguchi, Tatsuki Miyamoto

Pageof 1

Frequent Collaborators

3 joint publications

Tetsuro Watabe

1 joint publications

Miho Kobayashi

1 joint publications

Katarzyna A Podyma-Inoue

1 joint publications

Hiroki Inoue